GSK · GSK plc · Documents
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 2
5.39M
Avg daily vol (3M)
3.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-10-01 | — | |
| 6-K | 2026-09-24 | — | |
| 6-K | 2026-09-22 | — | |
| 6-K | 2026-09-15 | — | |
| 6-K | 2026-09-15 | — | |
| 6-K | 2026-09-14 | — | |
| 6-K | 2026-09-14 | — | |
| 6-K | 2026-09-11 | — | |
| 6-K | 2026-09-10 | — | |
| 6-K | 2026-09-10 | — | |
| 6-K | 2026-09-09 | — | |
| Investor Event Transcript | 2026-09-09 | 2026-09-30 | |
| Investor Event Transcript | 2026-09-09 | 2026-09-30 | |
| 6-K | 2026-09-09 | — | |
| 6-K | 2026-09-08 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-08-26 | — | |
| 6-K | 2026-08-24 | — | |
| 6-K | 2026-08-24 | — | |
| 6-K | 2026-08-24 | — | |
| 6-K | 2026-08-18 | — | |
| 6-K | 2026-08-13 | — | |
| 6-K | 2026-08-11 | — | |
| 6-K | 2026-08-03 | — | |
| 6-K | 2026-07-30 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-24 | — | |
| 6-K | 2026-07-24 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-07-16 | — | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-10 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-23 | — |
Showing 1–50 of 1,318 filings
Key facts
CIK
1131399
CUSIP
37733W204
13F (30d)
32 filings
22 filers
Visit website
Investor relations